Thursday, November 26, 2009

Rheumatoid Arthritis Home>
Rheumatoid Arthritis News>
FDA approves abuse-resistant painkiller

Font size
- A
- A
- A
Email This

Bookmark

Save

Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

FDA approves abuse-resistant painkiller

(Reuters) UPDATED 2009-08-13

The U.S. Food and Drug Administration (FDA) has approved a new formula of morphine-based drug that is designed to be harder to abuse. The drug, called Embeda, is meant to thwart people who chew or crush long-acting opioid medications to get a "high" from the drugs. It does this by encasing the painkiller in a compound that counteracts the opioid's effects if this casing is broken. The FDA has approved Embeda to treat moderate to severe pain when a patient needs a continuous opioid painkiller over an extended period. Read full story >

See all Rheumatoid Arthritis News

Related: morphine, opioids

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyRACentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.